Articles

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne
Department of Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand
Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne
Department of Pathology, University Hospital of Clermont-Ferrand, Clermont-Ferrand
Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne
Clinical Research Direction, University Hospital of Clermont-Ferrand, Clermont-Ferrand
Department of Hematology, University Hospital Sart Tilman, Liège
AP-HP, Henri Mondor Hospital, Pathology Department, F-94010 Créteil
Institute of Pathology, University Hospital Tübingen, Eberhard Karls University of Tübingen, Tübingen
Department of Pathology, University Hospital of Lille, Lille
Department of Pathology, University Centre Hospital, Rennes
Department of Pathology, CHU de Nantes
Department of Pathology, Institute Jules Bordet, Bruxelles
Centre Henri Becquerel, Service of Anatomical and Cytological Pathology, Centre Henri Becquerel Rouen, France, Rouen
Multisite pathology Institute, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite
Department of Pathology, CHU de Bordeaux, University of Bordeaux, Bordeaux
Department of Pathology, Le Mans Hospital Center, 72000 Le Mans
AP-HP, Henri Mondor Hospital, Pathology Department, F-94010 Créteil, France; University Paris Est Créteil, INSERM, IMRB, F-94010 Créteil
University Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France; Department of Immunobiology and Inserm U955, Henri Mondor University Hospital, Créteil
Department of Hematology, University Hospital of Lille, Lille
Department of Hematology, University Hospital of Rennes, Hospital Pontchaillou, Rennes
Department of Oncology, Louis Pasteur clinic, Essey-Lès-Nancy
University Paris Est Créteil, INSERM, IMRB, F-94010 Créteil, France; AP-HP, Henri Mondor Hospital, Lymphoid malignancies unit, F-94010 Créteil
Service of Hematology, Department of Oncology, Lausanne University, Hospital and Lausanne University, Lausanne
Department of Hematology, Hospital of Lens, Lens, France and Department of Hematology, University Hospital of Amiens, Amiens
Department of Hematology, Institute Curie, Hospital Rene Huguenin, Saint-Cloud
Department of Hematology, Sud-Francilien Hospital Centre, Corbeil-Essonnes
Department of Hematology, Hospital Centre of Blois, Blois
Department of Hematology, Hospital Centre Le Mans, Le Mans
Department of Hematology, Centre Hospitalier Lyon Sud and Inserm U1111, Pierre Bénite
Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm
Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne
AP-HP, Henri Mondor Hospital, Pathology Department, F-94010 Créteil, France; University Paris Est Créteil, INSERM, IMRB, F-94010 Créteil
Department of Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand
Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne
Haematologica Early view Jun 16, 2022 https://doi.org/10.3324/haematol.2022.281226